Literature DB >> 22426647

microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis.

Cheng-Long Li1, Hui Nie, Ming Wang, Li-Ping Su, Jian-Fang Li, Ying-Yan Yu, Min Yan, Qin-Long Qu, Zheng-Gang Zhu, Bing-Ya Liu.   

Abstract

microRNA-155 (miR-155), an important multifunctional microRNA, has been implicated in the development of multiple solid tumors, yet, its role in gastric cancer cells has not been fully elucidated. In this study, we find that miR-155 was significantly downregulated in gastric cancer cell lines compared with an immortalized gastric epithelial cell line (GES-1). Overexpression of miR-155 in SGC-7901 and MKN-45 gastric cancer cells dramatically suppressed cell migration, invasion and adhesion in vitro. Overexpression of miR-155 significantly reduced the protein levels of SMAD2 and repressed the activity of a luciferase reporter containing one of the two predicted miR-155 binding sites in SMAD2 3'-UTR, indicating that SMAD2 may be a miR-155 target gene. miR-155 expression was also remarkably restored by a DNA demethylating agent (5-Aza-2-deoxycytidine) in SGC-7901 and MKN-45 gastric cancer cells. Taken together, these data suggest that miR-155 may function as a tumor suppressor to regulate gastric cancer cell metastasis by targeting SMAD2, and its downregulation in gastric cancer cells may be partly ascribed to DNA methylation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426647     DOI: 10.3892/or.2012.1719

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  47 in total

Review 1.  MicroRNA in intervertebral disc degeneration.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2015-03-04       Impact factor: 6.831

Review 2.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

Review 3.  Levels of MicroRNA Heterogeneity in Cancer Biology.

Authors:  Nina Petrovic; Sercan Ergün; Esma R Isenovic
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

Review 4.  OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.

Authors:  Alexander A Svoronos; Donald M Engelman; Frank J Slack
Journal:  Cancer Res       Date:  2016-06-20       Impact factor: 12.701

Review 5.  Regulation of cancer metastasis by cell-free miRNAs.

Authors:  Maša Alečković; Yibin Kang
Journal:  Biochim Biophys Acta       Date:  2014-10-28

Review 6.  Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.

Authors:  Hasan Raza Kazmi; Soni Kumari; Satendra Tiwari; A Khanna; Gopeshwar Narayan
Journal:  Pathol Oncol Res       Date:  2018-03-19       Impact factor: 3.201

7.  MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1.

Authors:  Zhijun Ma; Yulan Ma; Qinghua Xia; Yong Li; Ruidong Li; Weilong Chang; Jinhuang Chen; Zhengwei Leng; Kaixiong Tao
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-08       Impact factor: 4.553

8.  Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease.

Authors:  Dániel Szűcs; Nóra Judit Béres; Réka Rokonay; Kriszta Boros; Katalin Borka; Zoltán Kiss; András Arató; Attila J Szabó; Ádám Vannay; Erna Sziksz; Csaba Bereczki; Gábor Veres
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

9.  MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells.

Authors:  Wei Chen; Liuxuan Huang; Chenjun Hao; Wenshu Zeng; Xu Luo; Xiaodi Li; Longshu Zhou; Songshan Jiang; Zheng Chen; Yuanli He
Journal:  Tumour Biol       Date:  2016-01-15

10.  Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2.

Authors:  Yuan-Xue Jiang; Zi-Ming Du; Lin Jiao; Qiong Shao; Sha Fu; Jian-Yong Shao; Xiao-Feng Zhu; Ingemar Ernberg; Yu-Hong Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.